Covid-19 Vaccine Trial: Findings Published in Med
T he findings of the Abogen- sponsored Phase 3 vaccine trial were published in the Cell Press’ journal Med . Led by Dr. Rakesh Kumar Gupta, Consultant in Respiratory Medicine, Head of the Pulmonology Department, and Deputy Medical Director at Lifecare Hospital, Musaffah, and Dr. Saad Aziz, Specialist in Pediatrics at Medeor Hospital, the teams demonstrated an outstanding effort by recruiting 992 participants in a record 10 days. The findings showed that the ABO1020 vaccine was effective against symptomatic COVID-19 in both elderly and younger adults, elicited robust neutralizing antibodies against Omicron BA.5 and XBB.1.5, and was safe and well- tolerated.
Feat Focus Burjeel Holdings 31
Made with FlippingBook - professional solution for displaying marketing and sales documents online